Talk:SARS-CoV-2 spike protein mutations
From Proteopedia
(Difference between revisions)
(→Table of variants and mutations discussed) |
|||
| (One intermediate revision not shown.) | |||
| Line 21: | Line 21: | ||
| | | | ||
| | | | ||
| - | | | + | | Novavax, JJ |
| | | | ||
|- | |- | ||
| Line 39: | Line 39: | ||
|- | |- | ||
| P.1 | | P.1 | ||
| - | | N501Y E484K | + | | N501Y K417T E484K |
| | | | ||
| - | | | + | | |
| | | | ||
| | | | ||
Current revision
Table of variants and mutations discussed
| Variant | ACE2 binding site | Furin site | Other sites | vaccines affected | vaccines unaffected |
|---|---|---|---|---|---|
| B.1.1.7 | N501Y | P681H | ΔH69 ΔV70 | Moderna, BioNTech | |
| B.1.351 | N501Y K417N E484K | Novavax, JJ | |||
| B.1.429 | L452R | ||||
| no name | Q677 P or H | ||||
| P.1 | N501Y K417T E484K |
Created with https://www.tablesgenerator.com/mediawiki_tables# using information from the main page. Information on variant P.1 from CDC.
--Karsten Theis 13:48, 24 February 2021 (UTC)
